An Economic Analysis of an Industry: Strategic Behavior of a Pharmaceutical Firm towards the End of a Drug Patent
This paper identifies the processes which are found within: bringing prescription drugs from the research and development phase to the sales and aftermarket phase. This paper explores how the drug companies are difficult to evaluate in terms of its impact on customers because of patents, the advertising, and prescription drug protectionism strategies.